Carrier system for water-soluble active ingredients
A water releasing composition in the form of an emulsion and process for using the composition are provided. The composition includes an aqueous phase and an oil phase. The aqueous phase includes at least one water-soluble active ingredient at a concentration by weight of from about 0.1% to about 20%, based upon weight of the composition. The oil phase includes dimethicone at a concentration by weight of about 1% to about 25%, and an emulsifying crosslinked siloxane elastomer at a concentration by weight of about 0.1% to about 20%, both based upon weight of the composition. The composition has a phase ratio of the aqueous phase to the oil phase of about 3.0 to about 12.0. The composition converts from an emulsion to a plurality of droplets upon application of shear.
1. A composition comprising:
an aqueous phase containing at least one water-soluble active ingredient at a concentration, by weight, of from about 0.1% to about 20%, based upon weight of the composition; and
an oil phase consisting of:
dimethicone, at a concentration, by weight, of from about 1% to about 25%, based upon weight of the composition;
an emulsifying crosslinked siloxane elastomer at a concentration, by weight, of about 0.1% to about 20%, based upon weight of the composition, the emulsifying crosslinked siloxane elastomer selected from the group consisting of dimethicone/PEG-10/15 crosspolymer, dimethicone/polyglycerin-3 crosspolymer, and a combination thereof; and
at least one of:
a co-emulsifier selected from the group consisting of lauryl PEG-9 polydimethylsiloxyethyl dimethicone, PEG-10 dimethicone, and a combination thereof;
tocopherol; and
a mixture of dimethicone and dimethiconol;
wherein a phase ratio of the aqueous phase to the oil phase is about 5 to about 9; and
wherein the composition converts from an emulsion to a plurality of droplets upon application of shear.
2. The composition of claim 1 , wherein the water-soluble active ingredient is chosen from flavones, stilbenoids, tannins, phenolic acids, polyphenolics, vitamins, xanthines, ceramides, cholesterols, sphingosines, C-glycosides, zwitterionic N-substituted amino sulfonic acid buffers, sugars, nucleic acids, a- and β-hydroxy acids, aminopropyl triethoxysilane, dihydroxyacetone, botanical extracts, amino acids, peptides, and combinations thereof.
3. The composition of claim 2 , wherein the at least one water-soluble active ingredient is chosen from phenolic or polyphenolic compounds, and combinations thereof.
4. The composition of claim 3 , wherein said phenolic or polyphenolic compound is baicalin.
5. The composition of claim 1 , wherein the emulsifying crosslinked siloxane elastomer is dimethicone/PEG-10/15 crosspolymer.
6. The composition of claim 1 , wherein the emulsifying crosslinked siloxane elastomer is dimethicone/polyglycerin-3 crosspolymer.
7. The composition of claim 1 , wherein the composition further includes at least one hydrotrope.
8. The composition of claim 7 , wherein the hydrotrope is selected from nicotinamide, caffeine, sodium PCA, sodium salicylate, urea, or hydroxyethyl urea.
9. The composition of claim 7 , wherein the hydrotrope is present in the composition in an amount of from about 0.1% to about 20% by weight, based on the weight of the composition.
10. The composition of claim 7 , wherein the hydrotrope is present in the composition in an amount of from about 0.5% to about 10% by weight, based on the weight of the composition.
11. The composition of claim 1 , wherein the co-emulsifier is at a concentration, by weight, of about 0.01% to about 1%, based upon weight of the composition.
12. The composition of claim 1 , further including a powder at a concentration by weight of from about 0.1% to about 5%, based upon weight of the composition.
13. A composition comprising:
(a) an aqueous phase including at least one water-soluble active ingredient chosen from baicalin, ferulic acid, adenosine, resveratrol, ascorbic acid, and hydroxypropyl tetrahydropyrantriol at a concentration, by weight, of from about 0.1% to about 10%, based upon weight of the composition, wherein the aqueous phase is at a concentration, by weight, of from about 80% to about 90%, based upon weight of the composition; and
(b) an oil phase consisting of:
dimethicone at a concentration, by weight, of from about 4% to about 20%, based upon weight of the composition;
an emulsifying crosslinked siloxane elastomer at a concentration, by weight, of about 0.5% to about 10%, based upon weight of the composition, the emulsifying crosslinked siloxane elastomer selected from the group consisting of dimethicone/PEG-10/15 crosspolymer, dimethicone/polyglycerin-3 crosspolymer, and a combination thereof; and
at least one of:
a co-emulsifier selected from the group consisting of lauryl PEG-9 polydimethylsiloxyethyl dimethicone, PEG-10 dimethicone, and a combination thereof;
tocopherol; and
a mixture of dimethicone and dimethiconol; and
(c) at least one hydrotrope chosen from nicotinamide and caffeine, at a concentration, by weight, of from about 0.5% to about 10% by weight;
wherein the composition converts from an emulsion to a plurality of droplets upon application of shear, and
wherein a phase ratio of the aqueous phase to the oil phase is about 5 to about 9.
14. A process for reducing signs of aging on a keratinous substrate comprising the steps of:
(1) applying the composition of claim 1 onto the keratinous substrate; and
(2) applying shear onto the composition, thereby transforming the composition into a plurality of droplets containing at least one water-soluble ingredient that is forced into the keratinous substrate.